AU2754599A - Mucosal microparticle conjugate vaccine - Google Patents
Mucosal microparticle conjugate vaccineInfo
- Publication number
- AU2754599A AU2754599A AU27545/99A AU2754599A AU2754599A AU 2754599 A AU2754599 A AU 2754599A AU 27545/99 A AU27545/99 A AU 27545/99A AU 2754599 A AU2754599 A AU 2754599A AU 2754599 A AU2754599 A AU 2754599A
- Authority
- AU
- Australia
- Prior art keywords
- mucosal
- conjugate vaccine
- microparticle conjugate
- microparticle
- vaccine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
- A61K47/6927—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6087—Polysaccharides; Lipopolysaccharides [LPS]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9800615A SE9800615D0 (en) | 1998-02-27 | 1998-02-27 | Mucosal microparticle conjugate vaccine |
SE9800615 | 1998-02-27 | ||
PCT/SE1999/000277 WO1999043349A1 (en) | 1998-02-27 | 1999-02-26 | Mucosal microparticle conjugate vaccine |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2754599A true AU2754599A (en) | 1999-09-15 |
Family
ID=20410340
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU27545/99A Abandoned AU2754599A (en) | 1998-02-27 | 1999-02-26 | Mucosal microparticle conjugate vaccine |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1059935A1 (en) |
JP (1) | JP2002504521A (en) |
AU (1) | AU2754599A (en) |
CA (1) | CA2322175A1 (en) |
NZ (1) | NZ507130A (en) |
SE (1) | SE9800615D0 (en) |
WO (1) | WO1999043349A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6682754B2 (en) | 1999-11-24 | 2004-01-27 | Willmar Poultry Company, Inc. | Ovo delivery of an immunogen containing implant |
US7132108B1 (en) | 2000-02-08 | 2006-11-07 | Agency For Science, Technology And Research | Biodegradable and biocompatible polymeric microspheres encapsulating Salmonella enteritidis bacteria |
AUPQ761200A0 (en) * | 2000-05-19 | 2000-06-15 | Hunter Immunology Limited | Compositions and methods for treatment of mucosal infections |
AUPR011700A0 (en) | 2000-09-14 | 2000-10-05 | Austin Research Institute, The | Composition comprising immunogenic virus sized particles (VSP) |
-
1998
- 1998-02-27 SE SE9800615A patent/SE9800615D0/en unknown
-
1999
- 1999-02-26 AU AU27545/99A patent/AU2754599A/en not_active Abandoned
- 1999-02-26 EP EP99908028A patent/EP1059935A1/en not_active Withdrawn
- 1999-02-26 WO PCT/SE1999/000277 patent/WO1999043349A1/en not_active Application Discontinuation
- 1999-02-26 NZ NZ507130A patent/NZ507130A/en unknown
- 1999-02-26 CA CA002322175A patent/CA2322175A1/en not_active Abandoned
- 1999-02-26 JP JP2000533144A patent/JP2002504521A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
CA2322175A1 (en) | 1999-09-02 |
WO1999043349A1 (en) | 1999-09-02 |
EP1059935A1 (en) | 2000-12-20 |
SE9800615D0 (en) | 1998-02-27 |
JP2002504521A (en) | 2002-02-12 |
NZ507130A (en) | 2002-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6065998A (en) | Influenza vaccine | |
AU9623898A (en) | Vaccines | |
GB9812613D0 (en) | Vaccine | |
AU4204097A (en) | Vaccine composition against malaria | |
AU1285300A (en) | Hiv vaccine | |
AU2544300A (en) | Immunogenic compounds | |
AU5977700A (en) | Vaccines | |
AU1600401A (en) | Malaria vaccine | |
GB0027072D0 (en) | Vaccine | |
AU6158700A (en) | Vaccine | |
AU2754599A (en) | Mucosal microparticle conjugate vaccine | |
AU5811600A (en) | Vaccine | |
AU6075498A (en) | Vaccines | |
AU2913600A (en) | Immunogenic compounds | |
AU4553100A (en) | Tumour-associated antigen | |
AU8877998A (en) | Oral vaccine | |
AU5274099A (en) | Hiv vaccine | |
AU1101701A (en) | Vaccine compositions | |
AU5084300A (en) | New vaccine formulations - 1 | |
AU3196000A (en) | 3,3'-diketotrehalose | |
AU4935700A (en) | New vaccine formulations-3 | |
GB9820956D0 (en) | Vaccine | |
GB9821821D0 (en) | Schistomiasis vaccine | |
GB9807805D0 (en) | Vaccine | |
AUPP546098A0 (en) | Vaccine strategy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC1 | Assignment before grant (sect. 113) |
Owner name: INNOVENTUS, UPPSALA LIFE SCIENCE AB Free format text: THE FORMER OWNER WAS: INGVAR SJOHOLM, LENA DEGLING WIKINGSSON |
|
PC1 | Assignment before grant (sect. 113) |
Owner name: INNOVENTUS PROJECT AB Free format text: THE FORMER OWNER WAS: INNOVENTUS, UPPSALA LIFE SCIENCE AB |
|
MK5 | Application lapsed section 142(2)(e) - patent request and compl. specification not accepted |